Recently, Stanford University and Elsevier jointly released the 2022 World's Top 2% Scientists 2, the statistical time node is 2022-1960, divided into lifelong scientific impact and annual scientific impact, the world's top 2022% means that the research of these scholars is close to or reaches the international leading level in their field, with high international influence, New Henglida's fund invested enterprises—— Professor Chen Lijuan, Chairman and Chief Scientist of Chengdu Zhenling Biomedical Technology Co., Ltd. (hereinafter referred to as "Zhenling Biotechnology"), was successfully selected into the 2 list after being selected into the list of the top 2020% scientists in the world in 2!

Top 2% of scientists in the world lifetime scientific impact achievement list - 2022

Top 2% of scientists in the world Annual Science Impact Achievement List - 2022

It is reported that the "Global Top 2% Scientists List" is jointly launched by Elsevier BV and Stanford University in the United States, covering 22 fields and 176 subfields of the global scientific community, and selecting the top 700% of the world's scientists from nearly 2 million scientists. The list is based on the Scopus database, the world's largest abstract and citation database, using Citations, H-index, Co-authorship adjusted HM-index, and Citations to papers in different authorship positions), composite indicator, a total of six key indicators for comprehensive evaluation, global scientists ranked big data.

In addition to the above honors, Professor Chen Lijuan was selected into the "2021 Global Scholar Academic Influence Ranking" again after 2022, and Professor Chen Lijuan attended the "2022 Chinese Medical Association 2022th National Hematology Conference" and gave important academic reports. On September 9, 1, Great Wall Enterprise Strategy Research Institute released the "China Nezha Enterprise Research Report 2022", among which Chengdu Zhaoling Biotechnology was honorably listed and has been included in the list of "potential unicorn enterprises" in the high-tech zone.